Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11058688
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 11059896
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11059907
Antibodies that bind Notum Pectinacetylesterase
granted -
US 11059879
Chimeric antigen receptor molecules and uses thereof
granted -
US 11058802
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11058722
Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain
granted -
US 11058645
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
granted -
US 11059780
Substituted pyrrolidine compound and use thereof
granted -
US 11060089
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted -
US 11052057
Use of cysteamine and derivatives thereof to suppress tumor metastases
granted -
US 11052144
Methods of tumor vaccination
granted -
US 11053262
Heterocyclic amide compounds having RORyT inhibitory action
granted -
US 11052064
Compositions, methods and systems for the treatment of cutaneous disorders
granted -
US 11053310
Antibodies for the treatment of cancers
granted -
US 11053314
Methods to eliminate cancer stem cells by targeting CD47
granted -
US 11052073
Sphingosine kinase 2 inhibitor for treating coronavirus infection
granted -
US 11052075
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
granted -
US 11051499
Genetically modified mice and engraftment
granted -
US 11053495
Multi-targeted single entity conjugates
granted -
US 11053484
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
granted -
US 11054423
Antibody-mediated neutralization of ebolaviruses
granted -
US 11053309
Methods for treating active eosinophilic esophagitis
granted -
US 11053290
Modified Tamm-Horsfall protein and related compositions and methods of use
granted -
US 11053284
Process for the preparation of cyclic depsipeptides
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.